Physician
PBS Anesthesia LLC
PBS Anesthesia LLC was paid $4.06M by Medicaid between Jan 2018 and Nov 2024, across 40 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoPBS ANESTHESIA LLC
LAS VEGAS, NV 89128
LAS VEGAS, NV 89128
33aNPI1740403658assigned 04/10/2007
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$4.06M
24GClaims121,622
24DCodes billed40
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Nevada
Rank by total paid#3 of 21
Median peer was paid$130K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,964 | $328K | |
| 2019 | 30,220 | $858K | |
| 2020 | 21,696 | $658K | |
| 2021 | 30,647 | $1.03M | |
| 2022 | 15,816 | $661K | |
| 2023 | 2,840 | $257K | |
| 2024incomplete | 2,439 | $266K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 25,878 | 20,770 | $1.22M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14% | 23,130 | 19,659 | $580K |
| 01992 | 9.3% | 3,533 | 3,259 | $376K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.0% | 11,091 | 9,751 | $366K |
| 01936 | 6.1% | 2,378 | 2,141 | $248K | |
| 00797 | 5.6% | 791 | 759 | $225K | |
| 00731 | 2.7% | 937 | 873 | $109K | |
| 00811 | 2.4% | 925 | 861 | $99K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 2.3% | 513 | 456 | $93K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1.9% | 1,740 | 1,472 | $78K |
| 00813 | 1.8% | 557 | 515 | $74K | |
| 01938 | 1.8% | 950 | 795 | $73K |
28 more codes
| 99156 | 1.6% | 1,157 | $66K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 7,105 | $65K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.4% | 629 | $58K |
| 64488 | 1.3% | 966 | $53K | |
| 99157 | 1.2% | 1,123 | $49K | |
| 00142 | 1.1% | 581 | $44K | |
| 99215 | Doctor's office visit, returning patient (complex) | 1.1% | 631 | $44K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 640 | $20K |
| 01937 | <1% | 244 | $19K | |
| 99253 | <1% | 1,031 | $18K | |
| 82570 | <1% | 16,100 | $13K | |
| 95955 | <1% | 966 | $11K | |
| 00630 | <1% | 72 | $11K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 6,963 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,762 | $7K |
| 20553 | <1% | 506 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,665 | $5K |
| 00790 | <1% | 13 | $4K | |
| 00120 | <1% | 14 | $3K | |
| 64483 | <1% | 25 | $3K | |
| 01935 | <1% | 19 | $2K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 211 | $1K |
| 80305 | <1% | 148 | $1K | |
| 96103 | <1% | 209 | $298.01 | |
| 99490 | Ccm add 20min | <1% | 33 | $238.28 |
| 94770 | <1% | 877 | $65.14 | |
| 96146 | <1% | 106 | $37.28 | |
| 80377 | 0% | 403 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, BETH (DIRECTOR OF OPERATIONS OWNER)
| Provider | Location | Paid |
|---|---|---|
| Winfield Laboratory Consultants, S.C. | Winfield, IL | $9K |
| Mountain Springs Counseling Center | Wasilla, AK | $8K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.